Research Highlights: In a Phase 1, first-in-human trial, a one-time infusion of an investigational CRISPR-Cas9 therapy targeting angiopoietin-like protein 3 (ANGPTL3) was safe and reduced LDL cholesterol by nearly 50% and reduced triglycerides by...
This is where cognitive dissonance takes people. He’s less interested in his theory’s predictive power than he is in its ability to distract him from reality.
This is where cognitive dissonance takes people. He’s less interested in his theory’s predictive power than he is in its ability to distract him from reality.